Abstract
Hypoxia is a complex pathophysiological condition. The physiological and molecular responses to this stress have been extensively studied. However, the management of its ill effects still poses a challenge to clinicians. MicroRNAs (miRNAs) are short non-coding RNA molecules that control post-transcriptional gene expression. The regulatory role of miRNAs in hypoxic environments has been studied in many hypoxia-related disorders, however a comprehensive compilation and analysis of all data and the significance of miRNAs in hypoxia adaption is still lacking. This review summarizes the miRNAs related to various hypoxia-related disorders and highlights the computational approaches to study them. This would help in designing novel strategies toward efficient management of hypoxia-related disorders.
Similar content being viewed by others
References
Acunzo M, Romano G, Wernicke D and Croce CM 2015 MicroRNA and cancer – a brief overview. Adv. Biol. Regul. 57 1–9
Alam P, Saini N and Pasha MA 2015 MicroRNAs: an apparent switch for high-altitude pulmonary edema. Microrna 4 158–167
Azzouzi HE, Leptidis S, Doevendans PA and De Windt LJ 2015 HypoxamiRs: regulators of cardiac hypoxia and energy metabolism. Trends Endocrinol. Metab. 26 502–508
Berra E, Pages G and Pouyssegur J 2000 MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev. 19 139–145
Boettger T and Braun T 2012 A new level of complexity: the role of microRNAs in cardiovascular development. Circ. Res. 110 1000–1013
Brown JM 2007 Tumor hypoxia in cancer therapy. Methods Enzymol. 435 297–321
Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, Scholz CC, Simpson DA, Leonard MO, Tambuwala MM, Cummins EP and Taylor CT 2011 MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 31 4087–4096
Buroker NE 2013 Circulating miRNAs from dried blood spots are associated with high altitude sickness. J. Med. Diagn. Meth. 2 1–7
Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM and Ragoussis J 2008 hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14 1340–1348
Chan YC, Khanna S, Roy S and Sen CK 2011 miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J. Biol. Chem. 286 2047–2056
Chen J and Wang DZ 2012 microRNAs in cardiovascular development. J. Mol. Cell. Cardiol. 52 949–957
Cheng C, Wang Q, You W, Chen M and Xia J 2014 MiRNAs as biomarkers of myocardial infarction: a meta-analysis. PLoS One 9 e88566
Chistiakov DA, Orekhov AN and Bobryshev YV 2016. The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease. J. Mol. Cell Cardiol. 97 47–55
Choudhry H, Harris AL and McIntyre A 2016 The tumour hypoxia induced non-coding transcriptome. Mol. Aspects Med. 47-48 35–53
Crosby ME, Kulshreshtha R, Ivan M and Glazer PM 2009 MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 69 1221–1229
Crystal RG 2001 Research opportunities and advances in lung disease. JAMA 285 612–618
El Baroudi M, Cora D, Bosia C, Osella M and Caselle M 2011 A curated database of miRNA mediated feed-forward loops involving MYC as master regulator. PLoS One 6 e14742
Felekkis K, Touvana E, Stefanou C and Deltas C 2010 microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia 14 236–240
Ferrara N 2002 VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2 795–803
Fuziwara CS and Kimura ET 2015 Insights into regulation of the miR-17-92 cluster of miRNAs in cancer. Front Med (Lausanne) 2 64
Ge RL, Simonson TS, Cooksey RC, Tanna U, Qin G, Huff CD, Witherspoon DJ, Xing J, Zhengzhong B, Prchal JT, Jorde LB and McClain DA 2012 Metabolic insight into mechanisms of high-altitude adaptation in Tibetans. Mol. Genet. Metab. 106 244–247
Gee HE, Ivan C, Calin GA and Ivan M 2014 HypoxamiRs and cancer: from biology to targeted therapy. Antioxid. Redox Signaling 21 1220–1238
Gluck AA, Aebersold DM, Zimmer Y and Medova M 2015 Interplay between receptor tyrosine kinases and hypoxia signaling in cancer. Int. J. Biochem. Cell Biol. 62 101–114
Greco S, Zaccagnini G, Voellenkle C and Martelli F 2016 microRNAs in ischaemic cardiovascular diseases. Eur. Heart J. Suppl. 18 E31–E36
Greijer AE and van der Wall E 2004 The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57 1009–1014
Gulyaeva LF and Kushlinskiy NE 2016 Regulatory mechanisms of microRNA expression. J. Transl. Med. 14 143
Gupta MK, Halley C, Duan ZH, Lappe J, Viterna J, Jana S, Augoff K, Mohan ML, Vasudevan NT, Na J, Sossey-Alaoui K, Liu X, Liu CG, Tang WH and Naga Prasad SV 2013 miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients. J. Mol. Cell Cardiol. 62 131–141
Hayes J, Peruzzi PP and Lawler S 2014 MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20 460–469
Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT and Giaccia AJ 2009 Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 35 856–867
Huang X, Le QT and Giaccia AJ 2010 MiR-210–micromanager of the hypoxia pathway. Trends Mol. Med. 16 230–237
Hubbi ME and Semenza GL 2015 Regulation of cell proliferation by hypoxia-inducible factors. Am. J. Physiol. Cell Physiol. 309 C775–C782
Huerta-Sanchez E, Degiorgio M, Pagani L, Tarekegn A, Ekong R, Antao T, Cardona A, Montgomery HE, Cavalleri GL, Robbins PA, Weale ME, Bradman N, Bekele E, Kivisild T, Tyler-Smith C and Nielsen R 2013 Genetic signatures reveal high-altitude adaptation in a set of Ethiopian populations. Mol. Biol. Evol. 30 1877–1888
Khorshidi A, Dhaliwal P and Yang BB 2016 Noncoding RNAs in tumor angiogenesis. Adv. Exp. Med. Biol. 927 217–241
Khurana P, Sugadev R, Jain J and Singh SB 2013 HypoxiaDB: a database of hypoxia-regulated proteins. Database (Oxford) 2013 bat074
Khurana P, Sugadev R, Sarkar S and Singh S 2016a A network-based analysis of proteins involved in hypoxia stress and identification of leader proteins. J. Proteomics Enzymol. 5 1–8
Khurana P, Tiwari D, Sugadev R, Sarkar S and Singh SB 2016b A comprehensive assessment of networks and pathways of hypoxia-associated proteins and identification of responsive protein modules. Netw. Model. Anal. Health Inform. Bioinform. 5 17
Koh MY and Powis G 2012 Passing the baton: the HIF switch. Trends Biochem. Sci. 37 364–372
Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA and Ivan M 2007 A microRNA signature of hypoxia. Mol. Cell Biol. 27 1859–1867
Lei Z, Li B, Yang Z, Fang H, Zhang GM, Feng ZH and Huang B 2009 Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS One 4 e7629
Li X, Gao L, Cui Q, Gary BD, Dyess DL, Taylor W, Shevde LA, Samant RS, Dean-Colomb W, Piazza GA and Xi Y 2012b Sulindac inhibits tumor cell invasion by suppressing NF-kappaB-mediated transcription of microRNAs. Oncogene 31 4979–4986
Li T, Li RS, Li YH, Zhong S, Chen YY, Zhang CM, Hu MM and Shen ZJ 2012a miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer. J. Urol. 187 1466–1472
Liu B, Huang H, Wang SX, Wu G, Xu G, Sun BD, Zhang EL and Gao YQ 2016 Physiological adjustments and circulating MicroRNA reprogramming are involved in early acclimatization to high altitude in Chinese Han males. Front. Physiol. 7 601
Liu S, Song N, He J, Yu X, Guo J, Jiao X, Ding X and Teng J 2017 Effect of hypoxia on the differentiation and the self-renewal of metanephrogenic mesenchymal stem cells. Stem Cells Int. 2017 7168687
Ma L 2010 Role of miR-10b in breast cancer metastasis. Breast Cancer Res. 12 210
Mattiske S, Suetani RJ, Neilsen PM and Callen DF 2012 The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol., Biomarkers Prev. 21 1236–1243
McCormick R, Buffa FM, Ragoussis J and Harris AL 2010 The role of hypoxia regulated microRNAs in cancer. Curr. Top. Microbiol. Immunol. 345 47–70
Mehta SR, Chawla A and Kashyap AS 2008 Acute mountain sickness, high altitude cerebral oedema, high altitude pulmonary oedema: the current concepts. Med. J. Armed Forces India 64 149–153
Noman MZ, Janji B, Berchem G and Chouaib S 2016 miR-210 and hypoxic microvesicles: two critical components of hypoxia involved in the regulation of killer cells function. Cancer Lett. 380 257–262
Nouraee N and Mowla SJ 2015 miRNA therapeutics in cardiovascular diseases: promises and problems. Front. Genet. 6 232
Paralikar SJ 2012 High altitude pulmonary edema-clinical features, pathophysiology, prevention and treatment. Indian J. Occup. Environ. Med. 16 59–62
Pinti MV, Hathaway QA and Hollander JM 2017 Role of microRNA in metabolic shift during heart failure. Am. J. Physiol. Heart Circ. Physiol. 312 H33–H45
Pinweha P, Rattanapornsompong K, Charoensawan V and Jitrapakdee S 2016 MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers. Comput. Struct. Biotechnol. J. 14 223–233
Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S and Rainaldi G 2006 MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108 3068–3071
Roy S and Sen CK 2012 miRNA in wound inflammation and angiogenesis. Microcirculation 19 224–232
Schuierer S, Tranchevent LC, Dengler U and Moreau Y 2010 Large-scale benchmark of endeavour using MetaCore maps. Bioinformatics 26 1922–1923
Sen CK 2011 MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicine. Physiol. Genomics 43 517–520
Sen CK and Roy S 2012 OxymiRs in cutaneous development, wound repair and regeneration. Semin. Cell Dev. Biol. 23 971–980
Shen G, Li X, Jia YF, Piazza GA and Xi Y 2013 Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol. Sin. 34 336–341
Shilo S, Roy S, Khanna S and Sen CK 2007 MicroRNA in cutaneous wound healing: a new paradigm. DNA Cell Biol. 26 227–237
Shilo S, Roy S, Khanna S and Sen CK 2008 Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb. Vasc. Biol. 28 471–477
Simon MC, Liu L, Barnhart BC and Young RM 2008 Hypoxia-induced signaling in the cardiovascular system. Annu. Rev. Physiol. 70 51–71
Srivastava M, Khurana P and Sugadev R 2012 Lung cancer signature biomarkers: tissue specific semantic similarity based clustering of digital differential display (DDD) data. BMC Res. Notes 5 617
Stadelmann WK, Digenis AG and Tobin GR 1998 Physiology and healing dynamics of chronic cutaneous wounds. Am. J. Surg. 176 26S–38S
Storz JF and Moriyama H 2008 Mechanisms of hemoglobin adaptation to high altitude hypoxia. High Alt. Med. Biol. 9 148–157
Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M and Sessa WC 2008 Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. U S A 105 14082–14087
Taylor CT and Cummins EP 2009 The role of NF-kappaB in hypoxia-induced gene expression. Ann. N Y Acad. Sci. 1177 178–184
Tili E, Croce CM and Michaille JJ 2009 miR-155: on the crosstalk between inflammation and cancer. Int. Rev. Immunol. 28 264–284
Vickers KC, Rye KA and Tabet F 2014 MicroRNAs in the onset and development of cardiovascular disease. Clin. Sci. (Lond.) 126 183–194
Wang J, Lu M, Qiu C and Cui Q 2010 TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res. 38 D119–D122
Wong LL, Wang J, Liew OW, Richards AM and Chen YT 2016 MicroRNA and heart failure. Int. J. Mol. Sci. 17 502
Yan Y, Shi Y, Wang C, Guo P, Wang J, Zhang CY and Zhang C 2015 Influence of a high-altitude hypoxic environment on human plasma microRNA profiles. Sci. Rep. 5 15156
Yan Y, Wang C, Zhou W, Shi Y, Guo P, Liu Y, Wang J, Zhang CY and Zhang C 2016 Elevation of circulating miR-210-3p in high-altitude hypoxic environment. Front. Physiol. 7 84
Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF, Lu MH, Tang Y, Yu HY and Sun SH 2009 Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 28 2719–2732
Yu AM, Tian Y, Tu MJ, Ho PY and Jilek JL 2016 MicroRNA pharmacoepigenetics: posttranscriptional regulation mechanisms behind variable drug disposition and strategy to develop more effective therapy. Drug. Metab. Dispos. 44 308–319
Zhang W, Liu J and Wang G 2014 The role of microRNAs in human breast cancer progression. Tumour Biol. 35 6235–6244
Zhang B, Qiangba Y, Shang P, Wang Z, Ma J, Wang L and Zhang H 2015a A comprehensive MicroRNA expression profile related to hypoxia adaptation in the Tibetan pig. PLoS One 10 e0143260
Zhang G, Shi H, Wang L, Zhou M, Wang Z, Liu X, Cheng L, Li W and Li X 2015b MicroRNA and transcription factor mediated regulatory network analysis reveals critical regulators and regulatory modules in myocardial infarction. PLoS One 10 e0135339
Zhang G, Xu Z and Wang N 2017 Network of microRNA, transcription factors, target genes and host genes in human mesothelioma. Exp. Ther. Med. 13 3039–3046
Zheng Q, Chen C, Guan H, Kang W and Yu C 2017 Prognostic role of microRNAs in human gastrointestinal cancer: a systematic review and meta-analysis. Oncotarget 8 46611–46623
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Ullas Kolthur-Seetharam.
Corresponding editor: Ullas Kolthur-Seetharam
Rights and permissions
About this article
Cite this article
Gupta, A., Sugadev, R., Sharma, Y.K. et al. Role of miRNAs in hypoxia-related disorders. J Biosci 43, 739–749 (2018). https://doi.org/10.1007/s12038-018-9789-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-018-9789-7